← Back to Screener
Outset Medical, Inc. Common Stock (OM)
Price$4.40
Favorite Metrics
Price vs S&P 500 (26W)-76.47%
Price vs S&P 500 (4W)24.03%
Market Capitalization$79.56M
All Metrics
Book Value / Share (Quarterly)$6.99
P/TBV (Annual)1.05x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)1.16%
Cash Flow / Share (Quarterly)$-2.59
Price vs S&P 500 (YTD)14.61%
Gross Margin (TTM)39.13%
Net Profit Margin (TTM)-68.34%
EPS (TTM)$-6.78
10-Day Avg Trading Volume0.10M
EPS Excl Extra (TTM)$-6.78
Revenue Growth (5Y)19.08%
EPS (Annual)$-5.37
ROI (Annual)-36.58%
Gross Margin (Annual)39.13%
Net Profit Margin (5Y Avg)-116.65%
Cash / Share (Quarterly)$9.30
Revenue Growth QoQ (YoY)-2.01%
ROA (Last FY)-30.87%
Revenue Growth TTM (YoY)5.09%
EBITD / Share (TTM)$-4.61
ROE (5Y Avg)-156.73%
Operating Margin (TTM)-62.26%
Cash Flow / Share (Annual)$-2.59
P/B Ratio0.63x
P/B Ratio (Quarterly)0.53x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)1.18x
Net Interest Coverage (TTM)-11.37x
ROA (TTM)-28.86%
EPS Incl Extra (Annual)$-5.37
Current Ratio (Annual)6.67x
Quick Ratio (Quarterly)5.24x
3-Month Avg Trading Volume0.63M
52-Week Price Return-60.67%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$3.03
P/S Ratio (Annual)0.67x
Asset Turnover (Annual)0.45x
52-Week High$21.98
Operating Margin (5Y Avg)-112.02%
EPS Excl Extra (Annual)$-5.37
CapEx CAGR (5Y)-38.55%
26-Week Price Return-72.49%
Quick Ratio (Annual)5.24x
13-Week Price Return-21.90%
Total Debt / Equity (Annual)0.76x
Current Ratio (Quarterly)6.67x
Enterprise Value$140.795
Revenue / Share Growth (5Y)46.38%
Asset Turnover (TTM)0.42x
Book Value / Share Growth (5Y)-1.91%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)1.36x
Pretax Margin (Annual)-67.74%
Cash / Share (Annual)$9.30
3-Month Return Std Dev91.63%
Gross Margin (5Y Avg)23.62%
Net Income / Employee (TTM)$-0
ROE (Last FY)-64.32%
Net Interest Coverage (Annual)-11.37x
EPS Basic Excl Extra (Annual)$-5.37
Receivables Turnover (TTM)3.74x
Total Debt / Equity (Quarterly)0.76x
EPS Incl Extra (TTM)$-6.78
Receivables Turnover (Annual)3.74x
ROI (TTM)-33.51%
P/S Ratio (TTM)0.67x
Pretax Margin (5Y Avg)-116.27%
Revenue / Share (Annual)$7.85
Tangible BV / Share (Annual)$5.08
Price vs S&P 500 (52W)-90.50%
Year-to-Date Return17.25%
5-Day Price Return0.69%
EPS Normalized (Annual)$-5.37
ROA (5Y Avg)-40.31%
Net Profit Margin (Annual)-68.34%
Month-to-Date Return13.28%
Cash Flow / Share (TTM)$-3.46
EBITD / Share (Annual)$-4.61
Operating Margin (Annual)-62.26%
LT Debt / Equity (Annual)0.76x
ROI (5Y Avg)-48.45%
LT Debt / Equity (Quarterly)0.76x
EPS Basic Excl Extra (TTM)$-6.78
P/TBV (Quarterly)1.69x
P/B Ratio (Annual)0.53x
Inventory Turnover (TTM)1.36x
Pretax Margin (TTM)-67.74%
Book Value / Share (Annual)$6.99
Price vs S&P 500 (13W)-22.59%
Beta1.98x
Revenue / Share (TTM)$6.58
ROE (TTM)-54.99%
52-Week Low$3.00
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.15
4.15
4.15
4.15
Industry Peers — Electromedical Equipment(29)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
OMOutset Medical, Inc. Common Stock | 0.67x | 19.08% | 39.13% | -62.26% | $4.40 |
MDTMedtronic plc | 3.13x | 3.01% | 65.16% | 17.00% | $85.65 |
MASIMasimo Corporation | 6.12x | 5.95% | 61.90% | 20.30% | $178.29 |
TMDXTransMedics Group, Inc. Common Stock | 6.58x | 88.21% | 59.92% | 17.93% | $109.12 |
LIVNLivaNova PLC Ordinary Shares | 2.56x | 8.24% | 68.04% | 14.09% | $65.01 |
ITGRInteger Holdings Corporation | 1.63x | 11.55% | 27.39% | 11.90% | $88.37 |
AXGNAxogen, Inc. Common Stock | 7.92x | 14.93% | 74.31% | -3.49% | $37.37 |
CNMDCONMED Corporation | 0.88x | 9.77% | 54.59% | 7.46% | $37.91 |
BLFSBioLife Solutions Inc. | 10.59x | 14.87% | 64.56% | -17.26% | $20.85 |
INMDInMode Ltd. Ordinary Shares | 2.45x | 12.45% | 78.54% | 23.05% | $14.33 |
CBLLCeriBell, Inc. Common Stock | 8.68x | — | 87.89% | -65.57% | $20.74 |
About
Outset Medical Inc manufactures the Tablo dialysis console, designed to reduce the cost and complexity of dialysis treatment. The company generates revenue from both capital equipment sales and recurring consumables, including cartridges and accessories. This dual revenue model captures both upfront and ongoing customer spend in the nephrology care market.